1) dihydropyridine calcium entry blocking agents
二氢吡啶类钙通道阻滞剂
1.
They were asked to stop dihydropyridine calcium entry blocking agents therapy and to receive once daily 10mg LH during 1 - 4 weeks, and retreated with dihydropyridine calcium entry blocking agent therapy during 5-8 weeks.
方法:采用自身双因素交叉试验法,入选50例患者,停用原来正服用的二氢吡啶类钙通道阻滞剂,1～4周改服盐酸乐卡地平,每次10mg(必要时增加到20mg),qd,5～8周恢复服用入选前的二氢吡啶类钙通道阻滞剂,患者在0,2,4,6和8周来医院就诊,整个临床试验过程中患者可继续应用原合并使用的利尿剂。
2) 1,4-dihydropyridine calcium channel blockers
1,4-二氢吡啶钙通道阻滞剂
3) DHPs calcium antagonist
二氢吡啶类钙拮抗剂
1.
The regulation and its mechanism of DHPs calcium antagonist on rat stomach fundus smooth muscle cell proliferation induced by 5-HT;
二氢吡啶类钙拮抗剂对抗5-HT引起的胃底平滑肌细胞的增殖及其机制
2.
Effect and it's mechanism of DHPs calcium antagonist on the 5-HT receptor of rat stomach fundus smooth muscle;
二氢吡啶类钙拮抗剂对大鼠胃底平滑肌5-HT受体功能的影响及其机制的研究
5) calcium channel blockers
钙通道阻滞剂
1.
Evaluation of Calcium Channel Blockers;
钙通道阻滞剂的临床应用评价
2.
Association between genetic polymorphism of CYP3A5 and blood concentration/dose ratio of cyclosporine combined with calcium channel blockers in renal transplant patients;
钙通道阻滞剂对肾移植患者环孢素血药浓度/剂量的影响与CYP3A5基因多态性有关
3.
A new method for simultaneous determination of four calcium channel blockers(nifedipine,nitrendipine,nimodipine and nicardipine)was presented based on the micellar electrokinetic chromatography (MEKC) separation of the analytes coupled to a dual-electrode and dual-channel electrochemical detection system.
建立了 4种钙通道阻滞剂 (硝苯地平、尼群地平、尼莫地平和尼卡地平 )的双通道胶束电动毛细管色谱电化学检测的分析新方法。
6) Calcium channel blocker
钙通道阻滞剂
1.
Relationship among calcium channel blocker,immunity and inflammation in cardiovascular diseases;
钙通道阻滞剂与心血管免疫炎症的关系
2.
Effect of calcium channel blocker on the contractility and autorhythmicity of isolated instable detrusor strip in rats;
钙通道阻滞剂对大鼠离体不稳定逼尿肌收缩性和自律性的影响
3.
OBJECTIVE: To investigate applicational status and development tendency of calcium channel blocker (CCB) in special hospital of heart disease.
目的:了解钙通道阻滞剂在心脏病专科医院的应用现状和发展趋势。
补充资料：钙通道阻滞剂
钙通道阻滞剂
calcium channel blockers
又称“钙拮抗剂”、“慢通道阻滞剂”。指能选择性的阻滞细胞膜上的钙通道，减少Ca2+经钙通道内流的一类药物。主要有二氢吡啶类(如硝苯吡啶、尼莫地平）苯烷胺类(如维拉帕米）和硫氮■类(如硫氮■酮）等。在钙通道蛋白上有此三类药物的高亲和力结合位点。具有扩张血管、降低血压、减弱心肌收缩力和抑制血小板聚集等作用。主要用于治疗冠心病、高血压病、室上性心动过速、脑血管疾病等。不同药物对不同部位组织有相对选择性，如硝苯吡啶扩张冠状血管作用比较显著，而尼莫地平扩张脑血管作用较强。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条